Eton Pharmaceuticals, Inc.
ETONFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Eton Pharmaceuticals, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 8 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 30, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | 2026-03-31 | 17,652 | Not shown | SEC filing |
| DEUTSCHE BANK AG\ | 2026-03-31 | 21,136 | $522K | SEC filing |
| JUNCTURE WEALTH STRATEGIES, LLC | 2026-03-31 | 19,181 | $473K | SEC filing |
| NEW YORK STATE COMMON RETIREMENT FUND | 2026-03-31 | 8,100 | $200K | SEC filing |
| Legal & General Group Plc | 2026-03-31 | 2,330 | $57.5K | SEC filing |
| JANE STREET GROUP, LLC | 2026-03-31 | 95,420 | $2.35M | SEC filing |
| Truvestments Capital LLC | 2026-03-31 | 1,183 | $29.2K | SEC filing |
| State of Alaska, Department of Revenue | 2026-03-31 | 6,943 | Not shown | SEC filing |
| Westside Investment Management, Inc. | 2026-03-31 | 467,915 | $11.5M | SEC filing |
| Mirae Asset Global Investments Co., Ltd. | 2026-03-31 | 1,399 | $34.5K | SEC filing |
| BlackRock, Inc. | 2026-03-31 | 1,717,286 | $42.4M | SEC filing |
| Woodline Partners LP | 2026-03-31 | 170,699 | $4.21M | SEC filing |
| TWIN PEAKS WEALTH ADVISORS, LLC | 2026-03-31 | 38 | $938 | SEC filing |
| Soleus Capital Management, L.P. | 2026-03-31 | 166,381 | $4.11M | SEC filing |
| JONES FINANCIAL COMPANIES LLLP | 2026-03-31 | 350 | $8.13K | SEC filing |
| UBS Group AG | 2026-03-31 | 168,958 | $4.17M | SEC filing |
| WELLS FARGO & COMPANY/MN | 2026-03-31 | 9,559 | $236K | SEC filing |
| PDT Partners, LLC | 2026-03-31 | 14,891 | $368K | SEC filing |
| Panoramic Capital, LLC | 2026-03-31 | 185,000 | $4.57M | SEC filing |
- Each value is checked against Eton Pharmaceuticals, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at Eton Pharmaceuticals, Inc.'s share price.
- 1 row left out: the value per share it reports is far from Eton Pharmaceuticals, Inc.'s share prices on file from around the report date, far from the value most filers reported for that date, or the value of a security already left out, so it may describe another security or share class.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security. Filers with a row left out above, or with no row above to check, are not listed.
- UBS Group AG: 126,674 shares reported 2025-12-31; 168,958 shares reported 2026-03-31.
- Mirae Asset Global Investments Co., Ltd.: 1,303 shares reported 2025-12-31; 1,399 shares reported 2026-03-31.
- NEW YORK STATE COMMON RETIREMENT FUND: 8,100 shares reported 2025-12-31; 8,100 shares reported 2026-03-31.
108 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Eton Pharmaceuticals, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-05-28 · BRYNJELSEN SEAN: Larger than 17 of the 18 other insider sales of Common Stock on file. SEC filing
- 2024-09-10 · Opaleye Management Inc.: Larger than 13 of the 14 other insider purchases of Common Stock, par value $0.001 per share on file. SEC filing
- 2021-04-12 · HARROW HEALTH, INC.: Larger than all 18 other insider sales of Common Stock on file. SEC filing
- 2020-10-16 · Opaleye Management Inc.: Larger than all 14 other insider purchases of Common Stock, par value $0.001 per share on file. SEC filing
Independent insiders buying near the same time
- 2021-08-20–2021-08-20: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2019-08-09–2019-08-13: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2018-11-15–2018-11-15: 6 event(s) across 6 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-17 | Adams Jennifer McKie · Director | Common Stock | S — Open market or private sale | −50,000 | 32.48 | SEC filing |
| 2026-05-28 | BRYNJELSEN SEAN · President & CEO | Common Stock | S — Open market or private sale | −148 | 32.67 | SEC filing |
| 2026-05-28 | BRYNJELSEN SEAN · President & CEO | Common Stock | S — Open market or private sale | −119,852 | 31.88 | SEC filing |
| 2026-05-27 | Krempa David · Chief Business Officer | Common Stock | S — Open market or private sale | −19,679 | 31.47 | SEC filing |
| 2026-05-26 | Krempa David · Chief Business Officer | Common Stock | S — Open market or private sale | −37,524 | 31.49 | SEC filing |
| 2026-05-22 | Krempa David · Chief Business Officer | Common Stock | S — Open market or private sale | −519 | 35.00 | SEC filing |
| 2026-05-22 | Krempa David · Chief Business Officer | Common Stock | S — Open market or private sale | −32,963 | 33.22 | SEC filing |
| 2026-05-22 | Krempa David · Chief Business Officer | Common Stock | S — Open market or private sale | −9,315 | 33.88 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-26 | Krempa David · Chief Business Officer | Restricted Stock Units | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-06-17 | Adams Jennifer McKie · Director | Employee Stock Option | M — Exercise or conversion of derivative security | −50,000 | SEC filing |
| 2026-06-17 | Adams Jennifer McKie · Director | Common Stock | M — Exercise or conversion of derivative security | +50,000 | SEC filing |
| 2026-05-27 | Krempa David · Chief Business Officer | Employee Stock Option | M — Exercise or conversion of derivative security | −12,476 | SEC filing |
| 2026-05-27 | Krempa David · Chief Business Officer | Employee Stock Option | M — Exercise or conversion of derivative security | −7,203 | SEC filing |
| 2026-05-27 | Krempa David · Chief Business Officer | Common Stock | M — Exercise or conversion of derivative security | +7,203 | SEC filing |
| 2026-05-27 | Krempa David · Chief Business Officer | Common Stock | M — Exercise or conversion of derivative security | +12,476 | SEC filing |
| 2026-05-26 | Krempa David · Chief Business Officer | Employee Stock Option | M — Exercise or conversion of derivative security | −12,524 | SEC filing |
Showing 8 of 28 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.